EUVIMEDEUVIMED entdecken
Crossref

Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China

Feiyan Pan, Xuejiao Chen, Yuanyuan Ying, Dandan He, Xinghong Di, Zehang He, Meizhen Dai, Huihui Xu

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.70002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Feiyan Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnosis Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Aneuploidy, Noninvasive Prenatal Testing, Prenatal Diagnosis. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Prenatal cell‐free DNA (cfDNA) screening has shown high accuracy for common trisomies, but its application in screening for sex chromosome aneuploidies (SCAs), rare autosomal aneuploidies (RAAs) or microdeletion/microduplication syndromes (MMSs) requires more supportive data.

Methods

Between 2017 and 2023, a total of 67,742 pregnant women were screened for foetal aneuploidies using cfDNA‐based next‐generation sequencing (NGS). Pregnant women with high‐risk results were recommended to undergo invasive prenatal diagnosis to confirm the findings and were explicitly offered the choice to accept or decline the procedure.

Results

A total of 1148 high‐risk results with foetal chromosome aneuploidies and/or copy number variations (CNVs) were identified from prenatal cfDNA screening. These cases included 432 common aneuploidies, 374 SCAs, 77 RAAs, and 265 CNVs. The positive predictive values (PPVs) were 82.6% (95% CI: 77.3%–86.9%) for T21, 56.3% (95% CI: 45.6%–66.7%) for T18%, and 33.9% (95% CI: 24.1%–47.3%) for T13. The overall PPVs were 45.5% (95% CI:38.9%–52.3%) for SCAs, 60.8% (95% CI: 51.6%–69.5%) for CNVs, and 57.8% (95% CI: 43.3%–71.4%) for known MMSs. Among the SCAs, the highest PPV was observed for 47,XXY (76.6%, 95% CI: 60.6%–84.8%), followed by 47,XXX (58.1%, 95% CI: 39.3%–72.9%), 45,X (33.1%, 95% CI: 26.1%–41.9%), and 47,XYY (30.8%, 95% CI: 15.5%–61.6%). Among the CNVs, 70.97% were determined to be pathogenic or likely pathogenic. Additionally, one false‐negative result for T21 and three cases of maternal malignancies were detected in our study population.

Conclusion

This study emphasises the significant clinical utility of prenatal cfDNA screening in assessing the risk of foetal chromosomal abnormalities; however, its applicability remains limited for RAA screening. Comprehensive long‐term phenotype follow‐up is essential to elucidate the clinical significance of CNVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsAneuploidyNoninvasive Prenatal TestingPrenatal DiagnosisChromosome DisordersHumansFemalePregnancyRetrospective StudiesChinaAdultDNA Copy Number Variations

Stichwörter der Autor:innen

cell‐free DNAchromosome aneuploidiescopy number variationskaryotypingnext‐generation sequencingnoninvasive prenatal screeningpositive predictive value

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Prenatal Diagnosis Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
  • Medical Research Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Pan, F., Chen, X., Ying, Y., He, D., Di, X., He, Z., Dai, M., & Xu, H. (2025). Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China. Prenatal Diagnosis. https://doi.org/10.1002/pd.70002

Vancouver

Pan F, Chen X, Ying Y, He D, Di X, He Z, et al. Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China. Prenatal Diagnosis. 2025. doi:10.1002/pd.70002

BibTeX
@article{Pan2025,
  author = {Pan, Feiyan and Chen, Xuejiao and Ying, Yuanyuan and He, Dandan and Di, Xinghong and He, Zehang and Dai, Meizhen and Xu, Huihui},
  title = {Performance of Prenatal Cell‐Free DNA Screening for Foetal Chromosome Aneuploidies and Microdeletion/Microduplication Syndromes: A Retrospective Study of 64,482 Consecutive Cases From a Prenatal Diagnosis Centre in China},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.70002}
}
Kostenlos starten →